Cardiac Involvement and Treatment-Related Mortality After Non-Myeloablative Haemopoietic Stem-Cell Transplantation With Unselected Autologous Peripheral Blood for Patients With Systemic Sclerosis: A Retrospective Analysis

Study Questions:

Should cardiac screening be used to risk stratify patients with systemic sclerosis being considered for hemopoietic stem-cell transplantation (HSCT)?